{"id":"W3016631762","doi":"10.1016/j.jtho.2020.03.029","title":"Canadian Multicenter Project on Standardization of Programmed Death-Ligand 1 Immunohistochemistry 22C3 Laboratory-Developed Tests for Pembrolizumab Therapy in NSCLC","year":2020,"lang":"en","type":"article","venue":"Journal of Thoracic Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"Nova Scotia Health Authority; Jewish General Hospital; Dalhousie University; University of Ottawa; Ottawa Hospital; University of Manitoba; McGill University; London Health Sciences Centre; Saint John Regional Hospital; University of British Columbia; Sunnybrook Health Science Centre; McMaster University; Manitoba Health; Credit Valley Hospital; Southlake Regional Health Center; Trillium Health Centre; St. Joseph’s Healthcare Hamilton; Institut universitaire de cardiologie et de pneumologie de Québec; McGill University Health Centre; Royal University Hospital; University of Toronto; University of Calgary; Health Sciences Centre; University of Alberta; University Health Network; Health Sciences North; Queen's University; Kingston General Hospital; Centre Hospitalier de l’Université de Montréal; Saskatchewan Health Authority; Université Laval; University of Saskatchewan","funders":"EMD Serono; Pfizer Canada; Merck; Merck Canada; AstraZeneca Canada; AstraZeneca; Pfizer; Bristol-Myers Squibb","keywords":"Pembrolizumab; Medicine; Standardization; Immunohistochemistry; Oncology; Internal medicine; Immunotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06452134,0.001341824,0.0007083133,0.003406479,0.003855179,0.00214753,0.005220265,0.001327813,0.002970677],"category_scores_gemma":[0.02388559,0.0006562286,0.0008525236,0.004073054,0.001537359,0.0005726115,0.002467342,0.001199246,0.001033768],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.04421603,"about_ca_system_score_gemma":0.1837585,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.8419775,"about_ca_topic_score_gemma":0.7844513,"domain_scores_codex":[0.9610909,0.01268188,0.001505494,0.002517044,0.01967922,0.002525559],"domain_scores_gemma":[0.8998453,0.003111437,0.005085982,0.004589749,0.0807757,0.006591745],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.006494804,0.002173127,0.2937244,0.002655207,0.000839912,0.0004400708,0.003281215,0.01003694,0.03992901,0.01641707,0.3202618,0.3037464],"study_design_scores_gemma":[0.001108585,0.002985866,0.559523,0.0008862936,0.0003759329,0.0003848866,0.00098916,0.007208891,0.02030558,0.0007324569,0.4053556,0.0001437435],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.3501438,0.02086253,0.1731668,0.03402741,0.002929082,0.09871636,0.1427027,0.005853188,0.1715981],"genre_scores_gemma":[0.6624803,0.003892957,0.2105854,0.006904252,0.0002782496,0.01971372,0.07413008,0.0007025194,0.0213126],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8419775,"threshold_uncertainty_score":0.3412256,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04385648591046105,"score_gpt":0.4225944784662735,"score_spread":0.3787379925558124,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}